Eszter Hazai
Eszter Hazai
Virtua Drug Ltd
Adresse e-mail validée de virtuadrug.com
Titre
Citée par
Citée par
Année
Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock
Z Bikadi, E Hazai
Journal of cheminformatics 1 (1), 15, 2009
4872009
Reduction of toxic metabolite formation of acetaminophen
E Hazai, L Vereczkey, K Monostory
Biochemical and Biophysical Research Communications 291 (4), 1089-1094, 2002
1292002
Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein
Z Bikadi, I Hazai, D Malik, K Jemnitz, Z Veres, P Hari, Z Ni, TW Loo, ...
PloS one 6 (10), e25815, 2011
1122011
Evaluation of drug–human serum albumin binding interactions with support vector machine aided online automated docking
F Zsila, Z Bikadi, D Malik, P Hari, I Pechan, A Berces, E Hazai
Bioinformatics 27 (13), 1806-1813, 2011
1082011
Functional and structural characterization of a protein based on analysis of its hydrogen bonding network by hydrogen bonding plot
Z Bikadi, L Demko, E Hazai
Archives of Biochemistry and Biophysics 461 (2), 225-234, 2007
1072007
Homology modeling of breast cancer resistance protein (ABCG2)
E Hazai, Z Bikádi
Journal of structural biology 162 (1), 63-74, 2008
1052008
Disordered proteins and network disorder in network descriptions of protein structure, dynamics and function: hypotheses and a comprehensive review
P Csermely, K Singh Sandhu, E Hazai, Z Hoksza, H JM Kiss, F Miozzo, ...
Current Protein and Peptide Science 13 (1), 19-33, 2012
712012
Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze …
E Hazai, D Kupfer
Drug metabolism and disposition 33 (1), 157-164, 2005
562005
Identification of a polyoxometalate inhibitor of the DNA binding activity of Sox2
K Narasimhan, S Pillay, NR Bin Ahmad, Z Bikadi, E Hazai, L Yan, ...
ACS chemical biology 6 (6), 573-581, 2011
552011
Natural product inspired antibacterial tetramic acid libraries with dual enzyme inhibition
YC Jeong, M Anwar, Z Bikadi, E Hazai, MG Moloney
Chemical Science 4 (3), 1008-1015, 2013
472013
Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase
E Hazai, Z Bikádi, F Zsila, SF Lockwood
Bioorganic & medicinal chemistry 14 (20), 6859-6867, 2006
432006
Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes
M Broekgaarden, R Weijer, M Krekorian, B van den IJssel, M Kos, ...
Nano Research 9 (6), 1639-1662, 2016
422016
Aggregation of cyclodextrins as an important factor to determine their complexation behavior
Z Bikádi, R Kurdi, S Balogh, J Szemán, E Hazai
Chemistry & biodiversity 3 (11), 1266-1278, 2006
402006
Predicting substrates of the human breast cancer resistance protein using a support vector machine method
E Hazai, I Hazai, I Ragueneau-Majlessi, SP Chung, Z Bikadi, Q Mao
BMC bioinformatics 14 (1), 130, 2013
392013
Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors
K Monostory, E Hazai, L Vereczkey
Chemico-biological interactions 147 (3), 331-340, 2004
392004
Interactions of granisetron with an agonist-free 5-HT3A receptor model
PR Joshi, A Suryanarayanan, E Hazai, MK Schulte, G Maksay, Z Bikádi
Biochemistry 45 (4), 1099-1105, 2006
382006
Binding of the pepper alkaloid piperine to bovine β-lactoglobulin: circular dichroism spectroscopy and molecular modeling study
F Zsila, E Hazai, L Sawyer
Journal of agricultural and food chemistry 53 (26), 10179-10185, 2005
362005
Molecular modeling of non-covalent binding of homochiral (3S, 3′ S)-astaxanthin to matrix metalloproteinase-13 (MMP-13)
Z Bikádi, E Hazai, F Zsila, SF Lockwood
Bioorganic & medicinal chemistry 14 (16), 5451-5458, 2006
312006
Selective binding of coumarin enantiomers to human α1-acid glycoprotein genetic variants
E Hazai, J Visy, I Fitos, Z Bikádi, M Simonyi
Bioorganic & medicinal chemistry 14 (6), 1959-1965, 2006
312006
Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation
MF Rosenberg, Z Bikadi, E Hazai, T Starborg, L Kelley, NE Chayen, ...
Acta Crystallographica Section D: Biological Crystallography 71 (8), 1725-1735, 2015
272015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20